Correlation between histological findings on punch biopsy specimens and subsequent excision specimens in cutaneous squamous cell carcinoma

Acta Dermato-Venereologica

Volumn 95, Issue 2, 2015, Pages 181-185

  Westers Attema, Annet ^a,b   Joosten, Valerie M H J ^a   Roozeboom, Marieke H ^a,b   Nelemans, Patty J ^c   Lohman, Bjorn G P M ^a   Botterweck, Anita A ^d   Steijlen, Peter M ^a,b   Van Marion, Arienne M W ^e   Kelleners Smeets, Nicole W J ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GROW Research Institute for Oncology and Developmental Biology   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Integraal Kankercentrum Limburg   (Netherlands)

^e VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; Punch biopsy; Squamous cell carcinoma; Surgical excision; TNM grouping stage; Treatment

Indexed keywords

ARTICLE; CANCER INFILTRATION; CANCER STAGING; CANCER SURGERY; CELL DIFFERENTIATION; CORRELATION ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; PERINEURAL INVASION; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN CARCINOMA; BIOPSY; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; LYMPH NODE METASTASIS; OBSERVER VARIATION; PATHOLOGY; PERIPHERAL NERVE; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SKIN NEOPLASMS; TUMOR INVASION;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBSERVER VARIATION; PERIPHERAL NERVES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84928256123     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1826     Document Type: Article

References (31)

1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 Suppl 61: 1–6.
2. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–1080.
3. Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989–2008. Eur J Cancer 2012; 48: 2046–2053.
4. de Vries E, Van de Poll-Franse lv, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152: 481–488.
5. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997; 133: 735–740.
6. Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 2000; 26: 521–530.
7. Netherlands CCCt. Number and research on cancer in the Netherlands, 2012. Available from: http://www.iknl.nl/page. php?id=298.
8. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El–Naggar AK, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23: 759–765.
9. Rowe DE, Carroll RJ, Day CL, Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976–990.
10. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713–720.
11. Brown SJ, Lawrence CM. The management of skin malignancy: to what extent should we rely on clinical diagnosis? Br J Dermatol 2006; 155: 100–103.
12. Heal CF, Raasch BA, Buettner PG, Weedon D. Accuracy of clinical diagnosis of skin lesions. Br J Dermatol 2008; 159: 661–668.
13. Sobin LH GM, Wittekind C. TNM classification of malignant tumours. 7 ed: John Wiley & Sons, 2009.
14. Bonerandi JJ, Beauvillain C, Caquant L, Chassagne JF, Chaussade V, Clavere P, et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol 2011; 25 Suppl 5: 1–51.
15. National health and medical research council. Clinical Practice Guidelines: Non-melanoma skin cancer: Guidelines for treatment and management in Australia, 2002 Canberra, Australia. Available from: http://www.nhmrc.gov.au/guidelines.
16. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002; 146: 18–25.
17. Network. NCC. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Basal cell and squamous cell skin cancers., 2012. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
18. Venereologie NVvDe. Nederlandse Vereniging voor Dermatologie en Venereologie. Guideline squamous cell carcinoma of the skin, 2010. Available from: http://www.huidarts.info/documents/?v=2&id=192.
19. Veness MJ. Advanced non melanoma skin cancer of the head and neck: an overview on management. Cancer forum 2006; 30: 195–201.
20. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007; 33: 885–899.
21. Roozeboom MH, Mosterd K, Winnepenninckx VJ, Nelemans PJ, Kelleners-Smeets NW. Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 894–898.
22. Wolberink EA, Pasch MC, Zeiler M, van Erp PE, Gerritsen MJ. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. J Eur Acad Dermatol Venereol 2013; 27: 985–989.
23. Russell EB, Carrington PR, Smoller BR. Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis. J Am Acad Dermatol 1999; 41: 69–71.
24. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF, Jr. Mohs micrographic surgery. J Am Acad Dermatol 1998; 39: 79–97.
25. Cassarino DS, Derienzo DP, Barr RJ, Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutan Pathol 2006; 33: 191–206.
26. de Visscher JG, Schaapveld M, Grond AJ, van der Waal I. Relationship of tumor thickness in punch biopsy and subsequent surgical specimens in stage I squamous cell carcinoma of the lower lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 141–144.
27. Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012; 106: 811–815.
28. Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas J Dermatol 2006; 47: 28–33.
29. Utikal J, Schadendorf D, Ugurel S. Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies. Arch Derm Res 2007; 298: 469–477.
30. Jensen V, Prasad AR, Smith A, Raju M, Wendel CS, Schmelz M, et al. Prognostic criteria for squamous cell cancer of the skin. J Surg Res 2010; 159: 509–516.
31. Son KD, Kim TJ, Lee YS, Park GS, Han KT, Lim JS, et al. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin. J Surg Oncol 2008; 97: 615–620.